Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients?
Nearly 1/3 of FIR PCa patients were upstaged to high-risk PCa at RP. Based on these findings, AS in clinical practice should only be considered after thorough patient counseling and performed using a stringent follow-up and staging regimen to minimize the risk of further disease progression. A key limitation is the lack of the percentage of Gleason pattern 4.
Authors
- Miriam Dellino (ORCID: https://orcid.org/0000-0003-3522-4648)
- Florian Roghmann (ORCID: https://orcid.org/0000-0003-0299-489X)
- Sebastian Berg (ORCID: https://orcid.org/0000-0002-5770-1575)
- Joachim Noldus (ORCID: https://orcid.org/0000-0001-5991-0146)
- Jan Philipp Radtke (ORCID: https://orcid.org/0000-0003-1009-6563)
- Karl H. Tully (ORCID: https://orcid.org/0000-0002-9499-0169)
- Analena Handke (ORCID: https://orcid.org/0009-0000-9472-8956)
- Rein‐Jüri Palisaar
- Christopher Orf
- Leon Miguel Garcia-Schürmann
Institutions
- University Hospitals of the Ruhr-University of Bochum (DE)
- Universitätsklinik Marien Hospital Herne (DE)
- Düsseldorf University Hospital (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-27
- DOI
- https://doi.org/10.3390/cancers17213444
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00